二氧化鈦:當用作食品添加劑時,E171 不再被認為是安全的

At the request of the European Commission in March 2020, EFSA updated its safety assessment of the food additive titanium dioxide (E 171).

The updated assessment revise a previous assessment published by EFSA in 2016, which highlighted the need for more research to fill data gaps.

EFSA's Expert Group on Food Additives and Flavorings (FAF) said: "Taking into account all available scientific research and data, the group concludes that titanium dioxide can no longer be considered a safe food additive. A key factor in reaching this conclusion However, we cannot rule out the genotoxicity problem after consuming titanium dioxide particles. After oral administration, the absorption rate of titanium dioxide particles is low, but it can accumulate in the body."

The assessment was conducted following a rigorous methodology and took into account thousands of studies since EFSA's last assessment in 2016, including new scientific evidence and data on nanoparticles.

For the first time, scientific experts have applied the 2018 EFSA Scientific Committee Nanotechnology Guidelines to the safety assessment of food additives. Titanium Dioxide E 171 contains up to 50% nanoscale particles (i.e. smaller than 100 nanometers) to which consumers may be exposed.

Genotoxicity assessment

Genotoxicity refers to the ability of chemicals to damage DNA, the genetic material of cells. Since genotoxicity may lead to carcinogenic effects, the potential genotoxic effects of a substance must be evaluated to draw conclusions about its safety.

Professor on the expert panel said: "While the evidence for general toxic effects is inconclusive, based on the new data and the fortification approach we cannot rule out concerns about genotoxicity and therefore we cannot determine a safe level for daily intake of the food additive."

The European Commission and risk managers in EU Member States have been informed of EFSA's conclusions and will consider appropriate actions to ensure consumers are protected.

background

Titanium dioxide (E 171) is authorized as a food additive in the EU according to Annex II of Regulation (EC) No 1333/2008.

The EFSA ANS panel re-evaluated the safety of the food additive E 171 in 2016 within the framework of Regulation (EU) No 257/2010 as part of the EU's re-evaluation program for food additives authorized before 20 January 2009.

In its 2016 opinion, the ANS panel recommended new research to fill the gap on possible effects on the reproductive system, which could allow them to set an acceptable daily intake (ADI). Uncertainties in the properties of materials used as food additives (E 171) were also highlighted, particularly with regard to the particle size and particle size distribution of titanium dioxide used as E 171.

In 2019, EFSA issued a statement on the French Agency for Food, Environmental and Occupational Health and Safety (ANSES) review of risks associated with exposure to the food additive titanium dioxide (E171). EFSA stressed in its statement that ANSES's opinion reiterates the uncertainties and data gaps previously identified by EFSA and does not present findings that invalidate the Authority's previous conclusions on the safety of titanium dioxide.

In the same year (2019), the Dutch Food and Consumer Product Safety Authority (NVWA) also issued an opinion on the possible health effects of the food additive titanium dioxide, emphasizing the importance of examining immunotoxicological effects in addition to potential reproductive toxicological effects .

Review

All comments are moderated before being published

HealthyPIG Magazine

View all
經痛治療點解咁多年都冇突破?最新方法、本地現況與未來方向

經痛治療點解咁多年都冇突破?最新方法、本地現況與未來方向

幾乎一半嘅世界人口,每個月都要面對一次——月經同經痛。由青春期到更年期,呢段時間長達三十幾年。雖然經痛唔係致命疾病,但對好多女性嚟講,每個月都係一次痛苦嘅循環,影響工作、學業同生活質素 [1]。咁問題嚟喇:點解咁多年嚟,經痛治療仲係停留喺熱水袋同布洛芬(ibuprofen)?

Celecoxib(西樂葆)介紹 — 藥理、歷史背景與臨床試驗

Celecoxib(西樂葆)介紹 — 藥理、歷史背景與臨床試驗

1. 藥物簡介與臨床用途 Celecoxib(商品名 Celebrex 等)係一種選擇性 COX-2 抑制劑,屬非類固醇抗炎藥(NSAID)。COX-2 喺炎症反應中會誘導前列腺素生成,從而引發疼痛及發炎;而 Celecoxib 有效抑制 COX-2,但對 COX-1 影響較少,因此相對常見 ...
用粟粉醃肉有乜科學根據?揭開中菜「滑肉」嘅秘密

用粟粉醃肉有乜科學根據?揭開中菜「滑肉」嘅秘密

前言:點解中餐炒肉咁滑? 好多香港人炒肉嘅時候都會發現,餐廳啲雞絲牛柳炒出嚟特別滑溜、唔鞋口。呢個秘密,唔喺高級食材,而係一個平凡但強大嘅材料——粟粉(Cornstarch)。 呢種技巧叫做**「走油前醃」或「滑油醃肉法」(Velveting)**,係中餐獨有技術之一,主要靠粟粉、蛋白、調味料...
咩係三價鐵(Fe³⁺)同二價鐵(Fe²⁺)?

咩係三價鐵(Fe³⁺)同二價鐵(Fe²⁺)?

當我哋講「鐵質」時,唔止係話有冇攝取足夠,而係講緊鐵喺人體內唔同形態(尤其係三價鐵 Fe³⁺ 同二價鐵 Fe²⁺)點樣被吸收、轉化、運輸同儲存,呢啲都深深影響生物可利用率

全面解構低鐵原因、病理機制及影響

全面解構低鐵原因、病理機制及影響

低鐵唔止係營養問題,仲可能係身體慢性警號

鐵質(iron)係人體不可或缺嘅微量元素,主要負責攜帶氧氣嘅血紅素(hemoglobin)製造、能量代謝、免疫調節等。當鐵質長期攝取不足、吸收差、或失去過多,就會導致「低鐵」(iron deficiency)甚至發展成「缺鐵性貧血」(iron deficiency anemia)。本文將從臨床醫學與分子生理角度,深入探討低鐵嘅成因、病理機制、生物轉化過程,以及其對人體造成嘅連鎖影響。

Obefazimod(ABX464):潰瘍性結腸炎新藥研究、作用機制與研發進展

Obefazimod(ABX464):潰瘍性結腸炎新藥研究、作用機制與研發進展

Obefazimod(又名 ABX464)係由法國生物科技公司 Abivax 開發嘅口服小分子創新藥,目標治療慢性發炎性腸道疾病(IBD),特別係潰瘍性結腸炎(UC)同克羅恩氏病(CD)患者。

夢遺係唔係一定關性事?

夢遺係唔係一定關性事?

夢遺,即係在無意識之下於睡眠中射精,係一種常見於青春期男生甚至成年男性身上的自然生理現象。夢遺唔等於一定發生性夢,也唔等於有性慾過強。它與睡眠週期中快速動眼期(REM sleep)嘅勃起模式有關,亦可能反映正常的荷爾蒙波動及精液排出節律。 咩係夢遺? 夢遺(nocturnal emission...
唔凍都會打冷震?

唔凍都會打冷震?

打冷震(shivering)唔一定因為天氣凍,喺情緒波動、發燒初期、焦慮、緊張等情況下都可以出現。打冷震係一種由大腦下視丘控制嘅「非意識性肌肉收縮」,目的係維持或調節核心體溫或應對突發壓力。了解打冷震背後嘅神經與體溫調節原理,可以幫我哋區分「正常生理反應」同「潛在疾病警號」。 打冷震係乜回事...
一緊張就流手汗?

一緊張就流手汗?

手掌汗腺主要受交感神經系統控制。當人面對壓力、驚訝、社交場合等刺激時,大腦會啟動「戰鬥或逃跑反應」,促使手掌、腳底等部位產生明顯出汗。這種情況屬於精神性出汗,與溫度無直接關係,係身體對外在壓力的自然反應。